Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Change in Cash: 2023-2024

Historic Change in Cash for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to $262.9 million.

  • Zenas BioPharma's Change in Cash fell 59.37% to $71.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$244.6 million, marking a year-over-year decrease of 185.00%. This contributed to the annual value of $262.9 million for FY2024, which is 2639.50% up from last year.
  • As of FY2024, Zenas BioPharma's Change in Cash stood at $262.9 million, which was up 2,639.50% from -$10.4 million recorded in FY2023.
  • Zenas BioPharma's Change in Cash's 5-year high stood at $262.9 million during FY2024, with a 5-year trough of -$10.4 million in FY2023.
  • Moreover, its 2-year median value for Change in Cash was $126.3 million (2023), whereas its average is $126.3 million.
  • Data for Zenas BioPharma's Change in Cash shows a peak YoY spiked of 2,639.50% (in 2024) over the last 5 years.
  • Over the past 2 years, Zenas BioPharma's Change in Cash (Yearly) stood at -$10.4 million in 2023, then skyrocketed by 2,639.50% to $262.9 million in 2024.